|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.76 SAR | +0.57% |
|
+1.46% | +5.78% |
| 06-04 | Morgan Stanley Lifts Almarai's PT, Affirms Overweight Rating | MT |
| 06-01 | BSF Capital Reduces Almarai's PT, Affirms Buy Rating | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.1 | 4.77 | 5.06 | 5.34 | 5.1 | |||||
Return on Total Capital | 4.8 | 5.65 | 6.02 | 6.41 | 6.11 | |||||
Return On Equity % | 9.62 | 10.58 | 11.79 | 12.64 | 12.5 | |||||
Return on Common Equity | 9.83 | 10.73 | 11.89 | 12.64 | 12.49 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 30.54 | 28.73 | 29.55 | 31.76 | 31.22 | |||||
SG&A Margin | 17.22 | 15.61 | 15.29 | 16.69 | 17.19 | |||||
EBITDA Margin % | 25.68 | 24.93 | 25.81 | 25.38 | 24.43 | |||||
EBITA Margin % | 13.26 | 13 | 14.14 | 14.63 | 14.01 | |||||
EBIT Margin % | 13.26 | 13 | 14.11 | 14.6 | 13.96 | |||||
Income From Continuing Operations Margin % | 9.96 | 9.5 | 10.48 | 11.03 | 11.13 | |||||
Net Income Margin % | 9.86 | 9.4 | 10.47 | 11.03 | 11.13 | |||||
Net Avail. For Common Margin % | 9.86 | 9.4 | 10.47 | 11.03 | 11.13 | |||||
Normalized Net Income Margin | 6.98 | 6.65 | 7.18 | 7.61 | 7.44 | |||||
Levered Free Cash Flow Margin | 11.42 | 2.08 | -1.77 | -1.69 | -7.2 | |||||
Unlevered Free Cash Flow Margin | 12.87 | 3.51 | 0.07 | -0.01 | -5.85 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.49 | 0.59 | 0.57 | 0.58 | 0.58 | |||||
Fixed Assets Turnover | 0.69 | 0.83 | 0.87 | 0.87 | 0.82 | |||||
Receivables Turnover (Average Receivables) | 11.83 | 12.61 | 11.38 | 11.66 | 11.99 | |||||
Inventory Turnover (Average Inventory) | 2.43 | 2.78 | 2.42 | 2.42 | 2.6 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.07 | 1.6 | 1.4 | 1.5 | 1.47 | |||||
Quick Ratio | 0.33 | 0.45 | 0.57 | 0.42 | 0.42 | |||||
Operating Cash Flow to Current Liabilities | 0.74 | 0.75 | 0.55 | 1.03 | 0.85 | |||||
Days Sales Outstanding (Average Receivables) | 30.86 | 28.95 | 32.08 | 31.38 | 30.44 | |||||
Days Outstanding Inventory (Average Inventory) | 150.18 | 131.18 | 150.67 | 151.26 | 140.57 | |||||
Average Days Payable Outstanding | 43.18 | 33.23 | 39.64 | 45.14 | 38.18 | |||||
Cash Conversion Cycle (Average Days) | 137.85 | 126.9 | 143.11 | 137.5 | 132.83 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 61.52 | 59.29 | 70.07 | 56.77 | 63.52 | |||||
Total Debt / Total Capital | 38.09 | 37.22 | 41.2 | 36.21 | 38.85 | |||||
LT Debt/Equity | 44.73 | 52.06 | 49.8 | 49.48 | 55.51 | |||||
Long-Term Debt / Total Capital | 27.69 | 32.68 | 29.28 | 31.56 | 33.95 | |||||
Total Liabilities / Total Assets | 47.67 | 47.05 | 50.8 | 47.17 | 48.64 | |||||
EBIT / Interest Expense | 5.71 | 5.69 | 4.8 | 5.45 | 6.49 | |||||
EBITDA / Interest Expense | 11.34 | 11.16 | 8.97 | 9.67 | 11.63 | |||||
(EBITDA - Capex) / Interest Expense | 5.55 | 6.04 | 2.71 | 1.08 | 0.27 | |||||
Total Debt / EBITDA | 2.45 | 2.11 | 2.42 | 1.96 | 2.36 | |||||
Net Debt / EBITDA | 2.3 | 1.99 | 1.91 | 1.86 | 2.27 | |||||
Total Debt / (EBITDA - Capex) | 5 | 3.9 | 7.98 | 17.57 | 100.38 | |||||
Net Debt / (EBITDA - Capex) | 4.7 | 3.68 | 6.33 | 16.7 | 96.35 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 3.21 | 18.12 | 4.56 | 7.17 | 5.17 | |||||
Gross Profit, 1 Yr. Growth % | -9.62 | 11.12 | 7.54 | 10.13 | 3.36 | |||||
EBITDA, 1 Yr. Growth % | -10.57 | 14.67 | 8.15 | 5.35 | 1.27 | |||||
EBITA, 1 Yr. Growth % | -19.23 | 15.86 | 13.43 | 10.9 | 0.76 | |||||
EBIT, 1 Yr. Growth % | -19.23 | 15.86 | 13.46 | 10.92 | 0.54 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -18.4 | 12.58 | 15.38 | 12.78 | 6.18 | |||||
Net Income, 1 Yr. Growth % | -21.21 | 12.55 | 16.44 | 12.88 | 6.18 | |||||
Normalized Net Income, 1 Yr. Growth % | -19.86 | 12.41 | 13.02 | 13.52 | 2.77 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -21.21 | 12.82 | 16.48 | 12.68 | 6.49 | |||||
Accounts Receivable, 1 Yr. Growth % | 9.99 | 9.29 | 21.89 | -9.71 | 15.62 | |||||
Inventory, 1 Yr. Growth % | -7.48 | 20.29 | 17.4 | -7.54 | 5.65 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -0.73 | -2.76 | 3.81 | 8.99 | 13.26 | |||||
Total Assets, 1 Yr. Growth % | -1.82 | 1.01 | 12.85 | -1.73 | 12.37 | |||||
Tangible Book Value, 1 Yr. Growth % | 3.6 | 3.57 | 7.4 | 5.91 | 7.11 | |||||
Common Equity, 1 Yr. Growth % | 2.76 | 3.42 | 6.76 | 5.58 | 9.24 | |||||
Cash From Operations, 1 Yr. Growth % | 16.94 | -22.09 | 17.05 | 34.49 | -9.38 | |||||
Capital Expenditures, 1 Yr. Growth % | 34.08 | 2.85 | 64.44 | 34.25 | 11.43 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 60.79 | -78.47 | -188.8 | 2.42 | 347.97 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 42.72 | -67.79 | -97.9 | -120.03 | 46.71K | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 0 | 0 | 15 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 5.09 | 10.41 | 11.13 | 5.86 | 6.17 | |||||
Gross Profit, 2 Yr. CAGR % | -3.35 | 0.22 | 9.32 | 11.3 | 6.69 | |||||
EBITDA, 2 Yr. CAGR % | -5.65 | 1.27 | 11.42 | 6.74 | 3.29 | |||||
EBITA, 2 Yr. CAGR % | -9.43 | -3.26 | 14.75 | 12.16 | 5.71 | |||||
EBIT, 2 Yr. CAGR % | -9.43 | -3.26 | 14.65 | 12.18 | 5.61 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -6.37 | -4.15 | 13.97 | 14.07 | 9.43 | |||||
Net Income, 2 Yr. CAGR % | -7.1 | -5.83 | 14.48 | 14.65 | 9.48 | |||||
Normalized Net Income, 2 Yr. CAGR % | -7.32 | -5.09 | 12.72 | 13.27 | 8.01 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -7.16 | -5.72 | 14.63 | 14.56 | 9.54 | |||||
Accounts Receivable, 2 Yr. CAGR % | 11.5 | 10.24 | 15.42 | 4.91 | 2.17 | |||||
Inventory, 2 Yr. CAGR % | 1.84 | 5.5 | 18.84 | 4.18 | -1.17 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -2.1 | -1.75 | 0.47 | 6.37 | 11.1 | |||||
Total Assets, 2 Yr. CAGR % | -2.12 | -0.42 | 6.76 | 5.31 | 5.08 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.28 | 3.59 | 5.47 | 6.65 | 6.51 | |||||
Common Equity, 2 Yr. CAGR % | 4.88 | 3.09 | 5.08 | 6.17 | 7.4 | |||||
Cash From Operations, 2 Yr. CAGR % | 1.91 | -4.55 | -4.5 | 25.47 | 10.39 | |||||
Capital Expenditures, 2 Yr. CAGR % | -3.2 | 17.43 | 30.05 | 48.58 | 22.31 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 32.62 | -41.16 | -56.28 | -4.63 | 114.2 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 21.21 | -32.2 | -91.78 | -93.52 | 868.25 | |||||
Dividend Per Share, 2 Yr. CAGR % | 8.47 | 0 | 0 | 0 | 7.24 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.34 | 9.27 | 8.43 | 9.8 | 5.63 | |||||
Gross Profit, 3 Yr. CAGR % | -3.14 | 1.25 | 2.6 | 11.24 | 8.59 | |||||
EBITDA, 3 Yr. CAGR % | -5.15 | 0.69 | 3.55 | 9.36 | 4.89 | |||||
EBITA, 3 Yr. CAGR % | -8.81 | -1.68 | 2.08 | 13.46 | 8.22 | |||||
EBIT, 3 Yr. CAGR % | -8.81 | -1.68 | 2.02 | 13.39 | 8.16 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -7.7 | -0.44 | 1.96 | 13.57 | 11.38 | |||||
Net Income, 3 Yr. CAGR % | -8.06 | -0.96 | 1.08 | 13.94 | 11.75 | |||||
Normalized Net Income, 3 Yr. CAGR % | -9.15 | -1.16 | 0.6 | 12.98 | 9.66 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -7.33 | -0.93 | 1.16 | 13.98 | 11.81 | |||||
Accounts Receivable, 3 Yr. CAGR % | 7.72 | 11.16 | 13.99 | 6.35 | 8.36 | |||||
Inventory, 3 Yr. CAGR % | 3.97 | 7.65 | 9.32 | 9.3 | 4.67 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -2.39 | -2.32 | 0.07 | 3.23 | 8.62 | |||||
Total Assets, 3 Yr. CAGR % | -1.06 | -1.09 | 3.82 | 3.85 | 7.61 | |||||
Tangible Book Value, 3 Yr. CAGR % | 5.3 | 4.71 | 4.84 | 5.62 | 6.8 | |||||
Common Equity, 3 Yr. CAGR % | 5.12 | 4.39 | 4.3 | 5.24 | 7.18 | |||||
Cash From Operations, 3 Yr. CAGR % | 10.24 | -6.81 | 2.17 | 7.04 | 12.57 | |||||
Capital Expenditures, 3 Yr. CAGR % | -7.1 | -1.22 | 31.38 | 31.43 | 34.99 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 63.44 | -27.65 | -32.52 | -41.94 | 59.72 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 143.86 | -22.07 | -78.72 | -88.95 | 25.26 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.57 | 5.57 | 0 | 0 | 4.77 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 2.02 | 6.08 | 7.62 | 7.89 | 7.52 | |||||
Gross Profit, 5 Yr. CAGR % | -2.6 | -0.74 | 1.66 | 5.16 | 5.16 | |||||
EBITDA, 5 Yr. CAGR % | -1.52 | -0.19 | 1.16 | 3.09 | 3.45 | |||||
EBITA, 5 Yr. CAGR % | -4.24 | -3.06 | -0.03 | 3.68 | 3.51 | |||||
EBIT, 5 Yr. CAGR % | -4.24 | -3.06 | -0.07 | 3.64 | 3.44 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -5.98 | -3.82 | 0.42 | 5.13 | 4.88 | |||||
Net Income, 5 Yr. CAGR % | -6.15 | -4.21 | 0.37 | 5.01 | 4.36 | |||||
Normalized Net Income, 5 Yr. CAGR % | -5.19 | -4.45 | -0.96 | 4.38 | 3.5 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -5.59 | -3.56 | 0.9 | 5 | 4.44 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.39 | 8.28 | 10.97 | 8.62 | 9.11 | |||||
Inventory, 5 Yr. CAGR % | 7.72 | 10.9 | 9.68 | 6.25 | 5 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 0.35 | -1.31 | -1.25 | 1.07 | 4.35 | |||||
Total Assets, 5 Yr. CAGR % | 1.7 | 0.11 | 2 | 1.42 | 4.32 | |||||
Tangible Book Value, 5 Yr. CAGR % | 4.52 | 2.93 | 5.37 | 5.48 | 5.5 | |||||
Common Equity, 5 Yr. CAGR % | 4.3 | 2.85 | 5.1 | 5.1 | 5.53 | |||||
Cash From Operations, 5 Yr. CAGR % | 1.9 | -3.66 | 4.09 | 4.96 | 5.38 | |||||
Capital Expenditures, 5 Yr. CAGR % | -16.44 | -8.75 | 6.28 | 16.3 | 27.67 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -0.49 | 12.13 | -3.55 | -19.2 | 7.11 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 4.55 | 81.84 | -37.17 | -71.19 | -2.02 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.79 | 5.92 | 3.3 | 3.3 | 2.83 |
- Stock Market
- Stocks
- 2280 Stock
- Financials Almarai Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















